Anti-Platelet Activity of Water Dispersible Curcuminoids in Rat Platelets

Phytotherapy Research

Volumn 29, Issue 3, 2015, Pages 450-458

  Maheswaraiah, Anikisetty ^a   Jaganmohan Rao, Lingamallu ^a   Naidu, Kamatham Akhilender ^a  

^a CENTRAL FOOD TECHNOLOGICAL RESEARCH INSTITUTE   (India)

Author keywords

12 LOX; curcuminoids; nitric oxide; platelet aggregation; superoxide; thromboxane

Indexed keywords

12 HYDROPEROXYEICOSATETRAENOIC ACID; ADENOSINE DIPHOSPHATE; ARACHIDONATE 12 LIPOXYGENASE; ARACHIDONIC ACID; COLLAGEN; CURCUMIN; CURCUMINOID DERIVATIVE; DEMETHOXYCURCUMIN; DIDEMETHOXYCURCUMIN; ICOSANOID; NITRIC OXIDE; POLYPHENOL; SEROTONIN; SUPEROXIDE; THROMBOXANE A2; UNCLASSIFIED DRUG; 12-HPETE; ANTITHROMBOCYTIC AGENT; LEUKOTRIENE; WATER;

ADULT; ANIMAL CELL; ANTICOAGULATION; ARTICLE; CHEMICAL COMPOSITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG POTENCY; ENZYME ACTIVITY; NONHUMAN; PROTEIN SECRETION; RAT; SEROTONIN RELEASE; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION INHIBITION; ANALOGS AND DERIVATIVES; ANIMAL; CHEMISTRY; CURCUMA; DRUG EFFECTS; METABOLISM; THROMBOCYTE AGGREGATION; WISTAR RAT;

CURCUMA LONGA; RATTUS;

ANIMALS; ARACHIDONATE 12-LIPOXYGENASE; ARACHIDONIC ACID; BLOOD PLATELETS; COLLAGEN; CURCUMA; CURCUMIN; LEUKOTRIENES; NITRIC OXIDE; PLATELET ACTIVATION; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; POLYPHENOLS; RATS; RATS, WISTAR; SEROTONIN; SUPEROXIDES; THROMBOXANE A2; WATER;

EID: 84924328188     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.5274     Document Type: Article

References (46)

1. Aggarwal BB, Kumar A, Bharti AC,. 2003. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 23: 363-398.
2. Aharony D, Smith JB, Silver MJ,. 1982. Regulation of arachidonate-induced platelet aggregation by the lipoxygenase product, 12-hydroxyeicosatetraenoic acid. Biochem Biophys Acta 718: 193-200.
3. Bennett CL, Connors JM, Carwile JM, et al,. 2000. Thrombotic and thrombocytopaenic purpura associated with clopidogrel. N Engl J Med 342: 1773-1777.
4. Born GV, Cross MJ,. 1963. The aggregation of blood platelets. J Physiol 168: 178-195.
5. Bradford MM,. 1976. Rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
6. Bruce F, Barbara F,. 2008. Mechanisms of Thrombus Formation. N Engl J Med 359: 938-949.
7. Bucher H, Hengstler P, Schindler C, Meier G,. 2002. N-3 Polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. Am J Med 112: 298-304.
8. Chang WC, Nakao J, Orimo H, Murota S,. 1982. Effects of reduced glutathione on the 12-lipoxygenasepathways in rat platelets. Biochem J 202: 771-776.
9. Cuendet M, Pezzuto JM,. 2000. The role of cyclooxygenase and lipoxygenase in cancer chemoprevention. Drug Metab Drug Interact 17: 109-157.
10. Deters M, Knochenwefel H, Lindhorst D, KoalT, MHH, Hänsel, RK, Kaever V,. 2008. Different curcuminoids inhibit T-Lymphocyte proliferation independently of their radical scavenging activities. Pharma Res 25: 1822-1827.
11. Dutta-Roy AK,. 2002. Dietary components and human platelet activity. Platelets 13: 67-75.
12. Elmi F, Peacock T, Schiavone J,. 2000. Isolated profound thrombocytopenia associated with clopidrogel. J Invasive Cardiol 12: 5352-535.
13. Eskra JD, Pereira MJ, Ernest MJ,. 1986. Solid-phase extraction and high-performance liquid chromatography analysis of lipoxygenase pathway products. Anal Biochem 154: 332-337.
14. Fonlup P, Croset M, Lagarde M,. 1991. 12-HETE inhibits the binding of PGH2/ TXA2 receptor ligands in human platelets. Thromb Res 63: 239-248.
15. Freedman JE, Loscalzo J, Barnard MR, Alpert C, Keaney JF, Michelson AD,. 1997. Nitric oxide released from activated platelets inhibits platelet recruitment. J Clin Invest 100: 350-356.
16. Freedman J, Parker C, Li L, et al,. 2001. Select flavonoids and whole juice from purple grapes inhibit platelet function and enhance nitric oxide. Circulation 103: 2792-2798.
17. Galan AM, Lopez-Vilchez I, Diaz-Ricart M, et al,. 2009. Serotonergic mechanisms enhance platelet-mediated thrombogenicity. Thromb Haemost 102: 511-519.
18. Gilmer JF, Murphy MA, Shannon JA, Breen CG, Ryder SA, Clancy JM,. 2003. Single oral dose study of two isosorbide-based aspirin prodrugs in the dog. J Pharm Pharmacol 55: 1351-1357.
19. Gkaliagkousi E, Ritter J, Ferro A,. 2007. Platelet-derived nitric oxide signaling and regulation. Circ Res 101: 654-662.
20. Golino P, Piscione F, Willerson JT, et al,. 1991. Divergent effects of serotonin on coronary-artery dimensions and blood flow in patients with coronary atherosclerosis and control patients. N Engl J Med 324: 641-648.
21. Gresele P, Pignatelli P, Guglielmini G, et al,. 2008. Resveratrol, at concentrations attainable with moderate wine consumption, stimulates human platelet nitric oxide production. J Nutr 138: 1602-1628.
22. Gum PA, Thamilarasan M, Watanabe J, Blackstone EH, Lauer MS,. 2001. Aspirin use and all-cause mortality among patients being evaluated for known or suspected coronary artery disease: A propensity analysis. JAMA 286: 1187-1194
23. Hamberg M, Samuelsson B,. 1974. Prostaglandin endoperoxides. Novel transformations of arachidonic acid in human platelets. Proc Natl Acad Sci U S A 71: 3400-3404.
24. Heptinstall S, Glenn JR, May JA, Storey RF, Wilcox RG,. 2004. Clopidogrel resistance. Catheter Cardiovasc Interv 63: 397-398.
25. Hong J, Bose M, Ju J, et al,. 2004. Modulation of arachidonic acid metabolism by curcumin and related (beta)-diketone derivatives: effects on cytosolic phospholipase A2, cyclooxygenases, and 5-lipoxygenase. Carcinogenesis 25: 1671-1679.
26. Hsu YC, Weng HC, Lin S, Chien YW,. 2007. Curcuminoids-cellular uptake by human primary colon cancer cells as quantitated by a sensitive HPLC assay and its relation with the inhibition of proliferation and apoptosis. J Agric Food Chem 55: 8213-8222.
27. Iqbal M, Sharma SD, Okazaki Y, Fujisawa M, Okada S,. 2003. Dietary supplementation of curcumin enhances antioxidant and phase II metabolizing enzymes in ddY male mice: possible role in protection against chemical carcinogenesis and toxicity. Pharmacol Toxicol 92: 33-38.
28. Jackson SP, Nesbitt WS, Kulkarni S,. 2003. Signaling events underlying thrombus formation. J Thromb Haemost 1: 1602-1612.
29. Jessie SW, Krishnakantha TP,. 2005. Inhibition of human platelet aggregation and membrane lipid peroxidation by food spice, saffron. Mol Cell Biochem 278: 59-63.
30. Joe B, Vijaykumar M, Lokesh BR,. 2004. Biological properties of Curcumin-cellular and molecular mechanisms of action. Crit Rev Food Sci Nutr 44: 97-111.
31. Kamath S, Blann AD, Lip GYH,. 2001. Platelets and atrial fibrillation. Eur Heart J 22: 2233-2242
32. Lagarden M, Chen P, Ve ricel E, Guichardant M,. 2010. Fatty acid derived lipid mediators and blood platelet aggregation. Prosta Leukot Essen Fatty Acids 82: 227-230.
33. Lefer AM, Smith EF, Araki H, et al,. 1980. Dissociation of vasoconstrictor and platelet aggregatory activities of thromboxane by carbocyclic thromboxane A2, a stable analog of thromboxane A2. Proc Natl Acad Sci U S A 77: 1706-1710.
34. Li N, Wallén NH, Ladjevardi M, Hjemdahl P,. 1997. Effects of serotonin on platelet activation in whole blood. Blood Coagul Fibrinolysis 8: 517-23.
35. Lopez-Vilchez I, Diaz-Ricart M, White JG, Escolar G, Galan AM,. 2009. Serotonin enhances platelet procoagulant properties and their activation induced during platelet tissue factor uptake. Cardiovasc Res 84: 309-316.
36. Osganian S, Stampfer M, Rimm E, Spiegelman D, Manson J, Willet W,. 2003. Dietary carotenoids and risk of coronary artery disease in women. Am J Clin Nutr 77: 1390-1399.
37. Pan MH, Huang TM, Lin JK,. 1999. Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metab Dispos 27: 486-494.
38. Pignatelli P, Di Santo S, Buchetti B, Sanguigni V, Brunelli A, Violi F,. 2006. Polyphenols enhance platelet nitric oxide by inhibiting protein kinase C-dependent NADPH oxidase activation: Effect on platelet recruitment. FASEB J 20: 1082-1089.
39. Raghavendra RH, Naidu KA,. 2009. Spice active principles as the inhibitors of human platelet aggregation and thromboxane biosynthesis. Prostag Leukot Essent Fatty Acids 81: 73-78
40. Rao LJM, Nagarajan S, Sampathu SR, and, Krishnamurthy N,. 2009. A process for the preparation of water soluble turmeric colourant formulations useful as yellow colourant in foods and beverages. Indian Patent 230571 dated 27-02-2009 (IP230571 Dt 22-02-2009).
41. Sandur SK, Pandey MK, Sung B, et al,. 2007. Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism. Carcinogenesis 28: 1765-1773.
42. Satoh K, Yatomi Y, Ozaki Y,. 2006. A new method for assessment of an anti-5HT 2A agent, sarpogrelate hydrochloride, on platelet aggregation. J Thromb Haemost 4: 479-48.
43. Schieffer GW,. 2002. Pressurized liquid extraction of curcuminoids and curcuminoid degradation products from turmeric (Curcuma longa) with subsequent HPLC assays. J Liq Chromatogr Relat Technol 25: 3033-3044.
44. Srivastava KC, Bordia A, Verma SK,. 1995. Curcumin, a major component of food spice turmeric (Curcuma longa) inhibits aggregation and alters eicosanoid metabolism in human blood platelets. Protag Leukot Essent Fatty Acids 52: 223-227.
45. Tarpey, MM, Wink, DA, Grisham, MB,. 2004. Methods for detection of reactive metabolites of oxygen and nitrogen: in vitro and in vivo considerations. Am J Physiol Regul Integr Comp Physiol 286: R431-R444.
46. Walther DJ, Peter JU, Winter S, Holtje M, et al,. 2003. Serotonylation of small GTPases is a signal transduction pathway that triggers platelet alpha-granule release. Cell 115: 851-862.